Gynecologic Cancers NOXXON ENTERS INTO COLLABORATION WITH US NATIONAL CANCER INSTITUTE TO CHARACTERIZE EFFECTS OF LEAD COMPOUNDS ON BRAIN TUMORSBy adminJune 14, 20220 Berlin, Germany – NOXXON Pharma N.V. (Euronext Growth Paris: ALNOX), a biotechnology company focused on improving cancer treatments by targeting…